MetaCap

Eton Pharmaceuticals (ETON) vs Immunome (IMNM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Eton Pharmaceuticals (ETON) has outperformed Immunome (IMNM) over the past year, gaining 269.7% versus a loss of 15.3%. Over five years, ETON leads with a +1341.9% price change compared with -7.5% for IMNM. Immunome is the larger company by market cap ($1.85 billion vs $1.76 billion), about 1.1 times the size, while Eton Pharmaceuticals is growing revenue faster (+104.9% vs -23.2%).

Eton Pharmaceuticals converts more of its revenue into profit, with a net margin of -5.8% versus -3060.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ETON+269.68%IMNM-15.33%
+332%+150%-32%
Nov 21, 20251 yearNov 20, 2026
ETON+1234.43%IMNM-8.78%
+1371%+607%-157%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ETON versus IMNM key metrics
MetricETONIMNM
Share price$60.85$15.69
Market cap$1.76B$1.85B
1-day change-0.83%-5.54%
YTD return+259.85%-26.96%
1-year return+269.68%-15.33%
5-year return+1341.94%-7.54%
P/E ratio (TTM)39.51—
Forward P/E18.41—
EPS (TTM)$1.54$-2.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$79.95M$6.94M
Revenue growth (YoY)+104.94%-23.23%
Net income (latest FY)$-4.60M$-212.39M
Gross margin53.46%—
Operating margin-1.06%-3228.83%
Net margin-5.75%-3059.99%
52-week high$70.64$30.06
52-week low$14.27$15.55
Distance from 52-week high-13.86%-47.80%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+32.70%+123.90%
Average volume570.79K1.36M
Shares outstanding28.84M118.07M
Employees44267
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ETON has outperformed IMNM by 285.0 percentage points over the past year.
  • Eton Pharmaceuticals is more profitable, keeping -5.8 cents of every revenue dollar as net income versus -3060.0 cents for Immunome.
  • Eton Pharmaceuticals grew revenue faster in its latest fiscal year (+104.94% vs -23.23%).

About Eton Pharmaceuticals

ETON stock →

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1.

Health Care · Biotechnology: Pharmaceutical Preparations · 44 employees

About Immunome

IMNM stock →

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial.

Health Care · Biotechnology: Pharmaceutical Preparations · 267 employees

ETON vs IMNM FAQ

Which is bigger, Eton Pharmaceuticals or Immunome?

Immunome (IMNM) is larger, with a market capitalization of $1.85B compared with $1.76B for Eton Pharmaceuticals (ETON).

Which stock has performed better over the past year, ETON or IMNM?

ETON returned +269.68% over the past 12 months, compared with -15.33% for IMNM (price return, excluding dividends). Past performance does not predict future results.

Are Eton Pharmaceuticals and Immunome in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons